Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D01FMS
|
||||
| Former ID |
DNC000237
|
||||
| Drug Name |
AP-Cav
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [535689] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C33H51ClN2O6
|
||||
| Canonical SMILES |
CC(C)[N+]1(C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3)C.CC(C)(C<br />)NCC(C1=CC(=C(C=C1)[O-])CO)O.Cl
|
||||
| InChI |
1S/C20H30NO3.C13H21NO3.ClH/c1-14(2)21(3)16-9-10-17(21)12-18(11-16)24-20(23)19(13-22)15-7-5-4-6-8-15;1-13(2,3)14-7-12(17)9-4-5-11(16)10(6-9)8-15;/h4-8,14,16-19,22H,9-13H2,1-3H3;4-6,12,14-17H,7-8H2,1-3H3;1H/q+1;;/p-1/t16-,17+,18?,19?,21?;12-;/m.0./s1
|
||||
| InChIKey |
ABSQYTODNZGQMD-ORLLXICISA-M
|
||||
| CAS Number |
CAS 22254-24-6
|
||||
| PubChem Compound ID | |||||
| PubChem Substance ID | |||||
| ChEBI ID |
ChEBI:46659
|
||||
| SuperDrug ATC ID |
C01CX10
|
||||
| SuperDrug CAS ID |
cas=022254246
|
||||
| Target and Pathway | |||||
| Target(s) | Nitric-oxide synthase, endothelial | Target Info | Inhibitor | [535689] | |
| BioCyc Pathway | Citrulline-nitric oxide cycle | ||||
| NetPath Pathway | Wnt Signaling Pathway | ||||
| Pathway Interaction Database | Plasma membrane estrogen receptor signaling | ||||
| Validated transcriptional targets of AP1 family members Fra1 and Fra2 | |||||
| Angiopoietin receptor Tie2-mediated signaling | |||||
| Thromboxane A2 receptor signaling | |||||
| SHP2 signaling | |||||
| VEGFR1 specific signals | |||||
| Signaling events mediated by VEGFR1 and VEGFR2 | |||||
| PAR1-mediated thrombin signaling events | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.